{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123324","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.011332+00:00","generated_at":"2026-05-30T03:35:43.434859+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Athira Pharma Q3 net loss $28.7M; LIFT-AD missed endpoints; exploring strategic alternatives","bullets":["Net loss $28.7M ($0.75/sh) vs $33.0M ($0.87/sh) Q3 2023; cash $68.9M down from $147.4M at Dec 2023.","Fosgonimeton (ATH-1017) LIFT-AD Phase 2/3 missed primary and key secondary endpoints; development paused.","Exploring strategic alternatives with Cantor Fitzgerald; ATH-1105 Phase 1 healthy volunteers on track for year-end 2024.","R&D expenses $17.9M vs $27.2M; G&A $7.6M vs $7.8M; legal accrual $4.1M from DOJ investigation.","Plan to begin dosing ATH-1105 in ALS patients in 2025; preclinical data supports HGF-modulating mechanism."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123324","json":"https://secwatch.observer/filing/0000950170-24-123324.json","markdown":"https://secwatch.observer/filing/0000950170-24-123324.md","text":"https://secwatch.observer/filing/0000950170-24-123324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024123324/0000950170-24-123324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024123324/atha-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:35:43.434859+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}